Cargando…
Comparing the Efficacy of Postoperative Pain Control Between Intravenous Parecoxib and Oral Diclofenac in ACL Reconstruction
BACKGROUND: A nonsteroidal anti-inflammatory drug such as oral diclofenac is normally used to relieve postoperative pain after anterior cruciate ligament reconstruction (ACLR), but most patients continue to have moderate-to-severe pain that disturbs their rehabilitation. Some orthopaedists prefer to...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532231/ https://www.ncbi.nlm.nih.gov/pubmed/34692879 http://dx.doi.org/10.1177/23259671211041660 |
_version_ | 1784587025863671808 |
---|---|
author | Chuaychoosakoon, Chaiwat Parinyakhup, Wachiraphan Wiwatboworn, Arnan Purngpiputtrakul, Peeranut Wanasitchaiwat, Pawin Boonriong, Tanarat |
author_facet | Chuaychoosakoon, Chaiwat Parinyakhup, Wachiraphan Wiwatboworn, Arnan Purngpiputtrakul, Peeranut Wanasitchaiwat, Pawin Boonriong, Tanarat |
author_sort | Chuaychoosakoon, Chaiwat |
collection | PubMed |
description | BACKGROUND: A nonsteroidal anti-inflammatory drug such as oral diclofenac is normally used to relieve postoperative pain after anterior cruciate ligament reconstruction (ACLR), but most patients continue to have moderate-to-severe pain that disturbs their rehabilitation. Some orthopaedists prefer to use intravenous (IV) parecoxib for postoperative pain control. PURPOSE: To compare the efficacy of IV parecoxib and oral diclofenac for postoperative pain control in ACLR. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: We retrospectively collected and analyzed postoperative pain in patients who underwent both single- and double-bundle ACLR; pain was reported on a 10-point visual analog scale (VAS; 10 = worst pain). After the operation, each patient was given either IV parecoxib twice a day or oral diclofenac 3 times a day, and all patients received paracetamol 6 times per day for 24 hours postoperatively. If the patient complained of moderate or severe pain (VAS >3) after surgery, 3 mg of morphine would be given intravenously every 3 hours and 1 mg of morphine as a rescue analgesic every 1 hour for 24 hours postoperatively. Postoperative VAS and morphine consumption were recorded every 4 hours for 24 hours. Data were analyzed using paired t test, analysis of variance, and chi-square test. RESULTS: Overall, 161 patients were included in this study, of whom 47 received IV parecoxib and 114 received oral diclofenac. The mean VAS scores at 4 and 8 hours postoperatively were 3.5 and 3.4, respectively, in the parecoxib group, and 4.4 and 4.7, respectively, in the diclofenac group. The parecoxib group had significantly lower mean VAS than the diclofenac group at 4 hours (P = .047) and 8 hours (P = .005), and the mean cumulative morphine consumption in the parecoxib group was significantly lower than in the diclofenac group at all time points (P < .05) except 4 hours postoperatively. CONCLUSION: This study found that IV parecoxib was more effective than oral diclofenac in controlling postoperative pain and resulted in lower postoperative morphine consumption within the first 24 hours after ACLR. |
format | Online Article Text |
id | pubmed-8532231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-85322312021-10-23 Comparing the Efficacy of Postoperative Pain Control Between Intravenous Parecoxib and Oral Diclofenac in ACL Reconstruction Chuaychoosakoon, Chaiwat Parinyakhup, Wachiraphan Wiwatboworn, Arnan Purngpiputtrakul, Peeranut Wanasitchaiwat, Pawin Boonriong, Tanarat Orthop J Sports Med Article BACKGROUND: A nonsteroidal anti-inflammatory drug such as oral diclofenac is normally used to relieve postoperative pain after anterior cruciate ligament reconstruction (ACLR), but most patients continue to have moderate-to-severe pain that disturbs their rehabilitation. Some orthopaedists prefer to use intravenous (IV) parecoxib for postoperative pain control. PURPOSE: To compare the efficacy of IV parecoxib and oral diclofenac for postoperative pain control in ACLR. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: We retrospectively collected and analyzed postoperative pain in patients who underwent both single- and double-bundle ACLR; pain was reported on a 10-point visual analog scale (VAS; 10 = worst pain). After the operation, each patient was given either IV parecoxib twice a day or oral diclofenac 3 times a day, and all patients received paracetamol 6 times per day for 24 hours postoperatively. If the patient complained of moderate or severe pain (VAS >3) after surgery, 3 mg of morphine would be given intravenously every 3 hours and 1 mg of morphine as a rescue analgesic every 1 hour for 24 hours postoperatively. Postoperative VAS and morphine consumption were recorded every 4 hours for 24 hours. Data were analyzed using paired t test, analysis of variance, and chi-square test. RESULTS: Overall, 161 patients were included in this study, of whom 47 received IV parecoxib and 114 received oral diclofenac. The mean VAS scores at 4 and 8 hours postoperatively were 3.5 and 3.4, respectively, in the parecoxib group, and 4.4 and 4.7, respectively, in the diclofenac group. The parecoxib group had significantly lower mean VAS than the diclofenac group at 4 hours (P = .047) and 8 hours (P = .005), and the mean cumulative morphine consumption in the parecoxib group was significantly lower than in the diclofenac group at all time points (P < .05) except 4 hours postoperatively. CONCLUSION: This study found that IV parecoxib was more effective than oral diclofenac in controlling postoperative pain and resulted in lower postoperative morphine consumption within the first 24 hours after ACLR. SAGE Publications 2021-10-20 /pmc/articles/PMC8532231/ /pubmed/34692879 http://dx.doi.org/10.1177/23259671211041660 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Article Chuaychoosakoon, Chaiwat Parinyakhup, Wachiraphan Wiwatboworn, Arnan Purngpiputtrakul, Peeranut Wanasitchaiwat, Pawin Boonriong, Tanarat Comparing the Efficacy of Postoperative Pain Control Between Intravenous Parecoxib and Oral Diclofenac in ACL Reconstruction |
title | Comparing the Efficacy of Postoperative Pain Control Between Intravenous Parecoxib and Oral Diclofenac in ACL Reconstruction |
title_full | Comparing the Efficacy of Postoperative Pain Control Between Intravenous Parecoxib and Oral Diclofenac in ACL Reconstruction |
title_fullStr | Comparing the Efficacy of Postoperative Pain Control Between Intravenous Parecoxib and Oral Diclofenac in ACL Reconstruction |
title_full_unstemmed | Comparing the Efficacy of Postoperative Pain Control Between Intravenous Parecoxib and Oral Diclofenac in ACL Reconstruction |
title_short | Comparing the Efficacy of Postoperative Pain Control Between Intravenous Parecoxib and Oral Diclofenac in ACL Reconstruction |
title_sort | comparing the efficacy of postoperative pain control between intravenous parecoxib and oral diclofenac in acl reconstruction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532231/ https://www.ncbi.nlm.nih.gov/pubmed/34692879 http://dx.doi.org/10.1177/23259671211041660 |
work_keys_str_mv | AT chuaychoosakoonchaiwat comparingtheefficacyofpostoperativepaincontrolbetweenintravenousparecoxibandoraldiclofenacinaclreconstruction AT parinyakhupwachiraphan comparingtheefficacyofpostoperativepaincontrolbetweenintravenousparecoxibandoraldiclofenacinaclreconstruction AT wiwatbowornarnan comparingtheefficacyofpostoperativepaincontrolbetweenintravenousparecoxibandoraldiclofenacinaclreconstruction AT purngpiputtrakulpeeranut comparingtheefficacyofpostoperativepaincontrolbetweenintravenousparecoxibandoraldiclofenacinaclreconstruction AT wanasitchaiwatpawin comparingtheefficacyofpostoperativepaincontrolbetweenintravenousparecoxibandoraldiclofenacinaclreconstruction AT boonriongtanarat comparingtheefficacyofpostoperativepaincontrolbetweenintravenousparecoxibandoraldiclofenacinaclreconstruction |